Literature DB >> 2413173

Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein.

A J Steck, N Murray, J C Justafre, C Meier, K V Toyka, K Heininger, G Stoll.   

Abstract

Serum or IgM fraction from two patients with a demyelinating neuropathy and IgM monoclonal antibodies to myelin-associated glycoprotein were injected in three different animal species. There were no clinical, electrophysiological or morphological signs of demyelination in either chronic or acute passive transfer experiments. These results suggest that the pathogenesis of this human demyelinating neuropathy may be more complex than has been assumed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413173      PMCID: PMC1028496          DOI: 10.1136/jnnp.48.9.927

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis.

Authors:  C Meier; K Roberts; A Steck; C Hess; E Miloni; L Tschopp
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

2.  Myasthenia gravis: passive transfer from man to mouse.

Authors:  K V Toyka; D B Brachman; A Pestronk; I Kao
Journal:  Science       Date:  1975-10-24       Impact factor: 47.728

3.  Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome.

Authors:  B Lang; J Newsom-Davis; D Wray; A Vincent; N Murray
Journal:  Lancet       Date:  1981-08-01       Impact factor: 79.321

4.  IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside.

Authors:  A A Ilyas; R H Quarles; T D MacIntosh; M J Dobersen; B D Trapp; M C Dalakas; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy.

Authors:  P E Braun; D E Frail; N Latov
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

6.  Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein.

Authors:  A J Steck; N Murray; C Meier; N Page; G Perruisseau
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

7.  Microangiopathy of vasa nervorum in dysglobulinemic neuropathy.

Authors:  H C Powell; M Rodriguez; R A Hughes
Journal:  Ann Neurol       Date:  1984-04       Impact factor: 10.422

8.  Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein.

Authors:  C Melmed; D Frail; I Duncan; P Braun; D Danoff; M Finlayson; J Stewart
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  Neuropathy accompanying IgM lambda monoclonal gammopathy.

Authors:  K Stefansson; L Marton; J P Antel; R L Wollmann; R P Roos; G Chejfec; B G Arnason
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

10.  Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G.

Authors:  K Heininger; U G Liebert; K V Toyka; F T Haneveld; G Schwendemann; V Kolb-Bachofen; H G Ross; S Cleveland; U A Besinger; E Gibbels
Journal:  J Neurol Sci       Date:  1984-10       Impact factor: 3.181

View more
  3 in total

Review 1.  Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.

Authors:  Luis Querol; Jérôme Devaux; Ricard Rojas-Garcia; Isabel Illa
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

2.  Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.

Authors:  C L Koski; D K Chou; F B Jungalwala
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

3.  Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG.

Authors:  A A Ilyas; Y Gu; M C Dalakas; R H Quarles; S Bhatt
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.